UAMS BioVentures Company Set To Go Public

by Mark Friedman  on Monday, Apr. 22, 2013 12:00 am   2 min read

Cyto Wave Technologies hopes to use this iV3 prototype to detect and kill cancer cells.  Vladimir Zharov, inset, developed the device with others

A University of Arkansas for Medical Sciences' BioVentures company that says it has a treatment that will detect and kill cancer cells is preparing to have its initial public offering.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access articles older than 15 days.
Articles newer than 15 days are not included in this offer.

Purchase Now

Already have archive access? Login to view this article.